These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 32812641)
1. miR-29b-3p inhibits post-infarct cardiac fibrosis by targeting FOS. Xue Y; Fan X; Yang R; Jiao Y; Li Y Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32812641 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1. Liu X; Xu Y; Deng Y; Li H Cell Physiol Biochem; 2018; 46(4):1439-1454. PubMed ID: 29689569 [TBL] [Abstract][Full Text] [Related]
3. The Smad3-miR-29b/miR-29c axis mediates the protective effect of macrophage migration inhibitory factor against cardiac fibrosis. Liang JN; Zou X; Fang XH; Xu JD; Xiao Z; Zhu JN; Li H; Yang J; Zeng N; Yuan SJ; Pan R; Fu YH; Zhang M; Luo JF; Wang S; Shan ZX Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2441-2450. PubMed ID: 31175931 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-323a-3p Promotes Pressure Overload-Induced Cardiac Fibrosis by Targeting TIMP3. Zhang J; Lang Y; Guo L; Pei Y; Hao S; Liang Z; Su G; Shu L; Liu H; Huang C; Xu J Cell Physiol Biochem; 2018; 50(6):2176-2187. PubMed ID: 30415251 [TBL] [Abstract][Full Text] [Related]
5. microRNA-29b Mediates the Antifibrotic Effect of Tanshinone IIA in Postinfarct Cardiac Remodeling. Yang F; Li P; Li H; Shi Q; Li S; Zhao L J Cardiovasc Pharmacol; 2015 May; 65(5):456-64. PubMed ID: 25636075 [TBL] [Abstract][Full Text] [Related]
6. Mir-21 Promotes Cardiac Fibrosis After Myocardial Infarction Via Targeting Smad7. Yuan J; Chen H; Ge D; Xu Y; Xu H; Yang Y; Gu M; Zhou Y; Zhu J; Ge T; Chen Q; Gao Y; Wang Y; Li X; Zhao Y Cell Physiol Biochem; 2017; 42(6):2207-2219. PubMed ID: 28817807 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-143-3p promotes human cardiac fibrosis via targeting sprouty3 after myocardial infarction. Li C; Li J; Xue K; Zhang J; Wang C; Zhang Q; Chen X; Gao C; Yu X; Sun L J Mol Cell Cardiol; 2019 Apr; 129():281-292. PubMed ID: 30878395 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway. Pan Z; Sun X; Shan H; Wang N; Wang J; Ren J; Feng S; Xie L; Lu C; Yuan Y; Zhang Y; Wang Y; Lu Y; Yang B Circulation; 2012 Aug; 126(7):840-50. PubMed ID: 22811578 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of circHIPK3 prevents angiotensin II-induced cardiac fibrosis by sponging miR-29b-3p. Ni H; Li W; Zhuge Y; Xu S; Wang Y; Chen Y; Shen G; Wang F Int J Cardiol; 2019 Oct; 292():188-196. PubMed ID: 30967276 [TBL] [Abstract][Full Text] [Related]
10. Apigenin suppresses TGF-β1-induced cardiac fibroblast differentiation and collagen synthesis through the downregulation of HIF-1α expression by miR-122-5p. Feng W; Ying Z; Ke F; Mei-Lin X Phytomedicine; 2021 Mar; 83():153481. PubMed ID: 33607460 [TBL] [Abstract][Full Text] [Related]
11. C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation. Lei H; Wu D; Wang JY; Li L; Zhang CL; Feng H; Fu FY; Wu LL Basic Res Cardiol; 2015; 110(4):35. PubMed ID: 25962701 [TBL] [Abstract][Full Text] [Related]
12. Modulation of miR-10a-mediated TGF-β1/Smads signaling affects atrial fibrillation-induced cardiac fibrosis and cardiac fibroblast proliferation. Li PF; He RH; Shi SB; Li R; Wang QT; Rao GT; Yang B Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30683806 [TBL] [Abstract][Full Text] [Related]
13. MiR-30b-5p and miR-22-3p restrain the fibrogenesis of post-myocardial infarction in mice via targeting PTAFR. Zhao XS; Ren Y; Wu Y; Ren HK; Chen H Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3993-4004. PubMed ID: 32329883 [TBL] [Abstract][Full Text] [Related]
14. MiR-590-3p regulates proliferation, migration and collagen synthesis of cardiac fibroblast by targeting ZEB1. Yuan X; Pan J; Wen L; Gong B; Li J; Gao H; Tan W; Liang S; Zhang H; Wang X J Cell Mol Med; 2020 Jan; 24(1):227-237. PubMed ID: 31675172 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of miR-195-3p protects against cardiac dysfunction and fibrosis after myocardial infarction. Carvalho A; Ji Z; Zhang R; Zuo W; Qu Y; Chen X; Tao Z; Ji J; Yao Y; Ma G Int J Cardiol; 2023 Sep; 387():131128. PubMed ID: 37356730 [TBL] [Abstract][Full Text] [Related]
16. LncRNA TUG1 Regulates Proliferation of Cardiac Fibroblast Guo Y; Sun Z; Chen M; Lun J Front Cardiovasc Med; 2021; 8():646806. PubMed ID: 34540908 [No Abstract] [Full Text] [Related]
17. LncRNA H19 Drives Proliferation of Cardiac Fibroblasts and Collagen Production via Suppression of the miR-29a-3p/miR-29b-3p-VEGFA/TGF-β Axis. Guo F; Tang C; Huang B; Gu L; Zhou J; Mo Z; Liu C; Liu Y Mol Cells; 2022 Mar; 45(3):122-133. PubMed ID: 34887365 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-29b-3p prevents Schistosoma japonicum-induced liver fibrosis by targeting COL1A1 and COL3A1. Tao R; Fan XX; Yu HJ; Ai G; Zhang HY; Kong HY; Song QQ; Huang Y; Huang JQ; Ning Q J Cell Biochem; 2018 Apr; 119(4):3199-3209. PubMed ID: 29091295 [TBL] [Abstract][Full Text] [Related]
19. Liver microRNA-29b-3p positively correlates with relative enhancement values of magnetic resonance imaging and represses liver fibrosis. Gong X; Wang X; Zhou F J Biochem; 2020 Dec; 168(6):603-609. PubMed ID: 32653922 [TBL] [Abstract][Full Text] [Related]
20. LncRNA MHRT Promotes Cardiac Fibrosis via miR-3185 Pathway Following Myocardial Infarction. Lang M; Ou D; Liu Z; Li Y; Zhang X; Zhang F Int Heart J; 2021; 62(4):891-899. PubMed ID: 34334583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]